ArticleCancer research2020

FIP200 Suppresses Immune Checkpoint Therapy Responses in Breast Cancers by Limiting AZI2/TBK1/IRF Signaling Independent of Its Canonical Autophagy Function.

Takako Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.